Deals

Dec 10, 2014
Pharmaceutical Executive
Rebecca Ashkenazy, Alex Chang, Cyndi Green, Ted Miller, and Christine de los Reyes discuss how the 3S framework - science, synergy, and survival -- can build more value in biopharmaceutical dealmaking.
Apr 28, 2014
By Pharmaceutical Executive Editors
Genpact to Acquire Regulatory Affairs Company
Apr 01, 2013
Pharmaceutical Executive
Pharm Exec's annual look at the trends and best practices in biopharm licensing and M&A for the year ahead.
Mar 01, 2013
Pharmaceutical Executive
As small biotech firms test the water in partnerships with Big Pharma, the best calling card is a well-framed strategy on intellectual property.
Dec 01, 2012
Pharmaceutical Executive
By Pharmaceutical Executive Editors
Eli Lilly's pioneering pact with leading CRO Covance made big news when it happened. Four years later, both parties can point to metrics that suggest the benefit is mutual.
Jun 01, 2012
Pharmaceutical Executive
Pharm Exec convened a panel of heavy hitters in business development to crack the bat on best practices in licensing and M&A for the year ahead.
Dec 01, 2011
Pharmaceutical Executive
It's a neck and neck race toward safer, faster, and medically superior treatments. Which organizations have what it takes to jockey their products into the winner's circle?
Oct 01, 2011
Pharmaceutical Executive
By Pharmaceutical Executive Editors
Top 10 Products Worldwide
Oct 01, 2011
Pharmaceutical Executive
By Pharmaceutical Executive Editors
30 Years of Pharma: Perspective in Numbers
Oct 01, 2011
Pharmaceutical Executive
By Pharmaceutical Executive Editors
Top 10 Companies by Market Share
native1_300x100
lorem ipsum